If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: -5.00 (-1.02%)
Spread: 10.00 (2.083%)
Open: 490.00
High: 490.00
Low: 485.00
Prev. Close: 490.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jan 2010 07:00

RNS Number : 7493F
BrainJuicer Group PLC
19 January 2010
 



Press release 

19 January 2010

BrainJuicer Group PLC

("BrainJuicer" or "the Group" or "the Company")

Trading Update

Profitable growth

Leading international online market researcher, BrainJuicer Group PLC, today gives the following update on trading ahead of its Preliminary Results for the financial year ended 31 December 2009 which will be announced on 9 March 2010.

Highlights:

 

·;  
Results expected to be in line with market expectations; profitable growth continues despite difficult market conditions and significant investment in product development, operations and technology
·;
Revenue up around 26% to approximately £11.7 million (2008: £9.3 million)
·;
Operating profit up by more than 25% to over £1.6 million (2008: £1.29 million)
·;
Strong financial position with cash up to around £2.3 million at 31 December 2009 (30 June 2009: £1.2m) and no debt
·;
Innovative ‘Juicy’ products grew 65% to over 60% of turnover [2008: 46%]
·;
Working with 11 of the world’s top 20 buyers of market research [9 in 2008]
·;
Both new offices, Switzerland and Germany achieved profitability in their first 18 months

BrainJuicer's reputation for innovation grew further in 2009 with revenue from the Group's strategically important 'Juicy' products making significant gains and now accounting for over 60% of the Group's revenue (2008: 46%). These products are being sold to some of the world's largest buyers of market research. In 2009 the Company's clients included 11 of the world's top 20 buyers of market research, up from 9 in 2008, and revenue from these clients grew by over 70%. Client satisfaction remains high with repeat business at around 80%.

Revenue increase was driven by continued strong progress in the US, growing at around 60%, and by very encouraging contributions from the new offices in Switzerland and Germany. The Company's  UK business recovered after a slow start to the year (revenue for the full year was around 2% lower), and Dutch revenue grew about 10%. Overall the Group achieved approximately 26% revenue growth (21% on a constant currency basis).

Operating profit is up by more than 25whilst having at the same time invested more than ever before in developing and validating productsin back-office operations and in the Company's software  platform. We believe this investment will drive future growth.

The Group has reached an agreement to acquire High Level Research Inc., its Canadian licencee, for a nominal sum This will be managed as a regional office within our North American business.

John KearonCEO of BrainJuicer, commented: "To have grown so strongly in a year when spending on market research seems to have declined for the first time in 25 years is a tremendous achievement and testament to the attraction of our innovative 'Juicy' products, expanded geographic footprint and talented researchers to our major multinational client base. Despite the dire economic conditions, we have continued to make significant investments.  Whilst many of the largest research agencies have apparently declined and retrenched during 2009, we continued to invest heavily in new and existing 'Juicy' products, enhancing the efficiency and scalability of our technology platform and expanding our geographic footprint. These investments will, we believe, enable us to secure the global and regional mandates which we need to fulfil our longer term ambitions.

"The Board is confident that in 2010 we can continue to grow our business through  further product  innovation and increasing our market share with major multinational customers."

An analyst presentation, given by John KearonCEO, and James Geddes, CFO, will be held at 9.30am on 9 March 2010 at Abchurch's office, 16th Floor, 125 Old Broad StreetLondonEC2N 1AR.

- Ends -

For further information, please contact:

BrainJuicer Group PLC

Tel: +44 (0) 20 7043 1000

John Kearon, Chief Executive Officer

john.kearon@brainjuicer.com

James Geddes, Chief Financial Officer

james.geddes@brainjuicer.com

Canaccord Adams

Tel: +44 (0) 20 7050 6500

Mark Williams / Henry Fitzgerald-O'Connor

www.canaccordadams.com

Media enquiries:

Abchurch Communications

Heather Salmond / Joanne Shears

Tel: +44 (0) 20 7398 7709

joanne.shears@abchurch-group.com

www.abchurch-group.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWOWRROAAAAR
Date   Source Headline
16th Apr 20247:00 amRNSTrading Update
24th Jan 20247:00 amRNSTrading Update
12th Dec 202312:51 pmRNSPresentation via Investor Meet Company
6th Dec 20237:00 amRNSChange of Auditor
6th Dec 20237:00 amRNSInterim Results
24th Oct 20237:00 amRNSTrading Update
27th Sep 20236:00 pmRNSResult of AGM
27th Sep 20237:00 amRNSTrading Update
31st Aug 20237:00 amRNSAnnual Report and Notice of AGM
1st Aug 20237:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2023
31st Jul 20232:00 pmRNSPreliminary Results Presentation
13th Jul 20237:30 amRNSTrading update
30th Jun 20239:00 amRNSResolution of Complaint for Trademark Infringement
28th Jun 202311:00 amRNSHolding(s) in Company
3rd May 20233:15 pmRNSFurther re Result of General Meeting
21st Apr 202311:56 amRNSResult of General Meeting
13th Apr 20237:00 amRNSFurther re Requisitioned General Meeting
12th Apr 20237:00 amRNSTrading Update
5th Apr 202310:45 amRNSNotice of Trading Update
24th Mar 20234:00 pmRNSPosting of Circular and Notice of Requisitioned GM
24th Mar 20237:00 amRNSPosting of Circular and Notice of Requisitioned GM
7th Mar 20237:30 amRNSReceipt of Requisition Notice
28th Feb 202312:50 pmRNSCapital Markets Day
23rd Feb 20237:00 amRNSTrading Update
14th Feb 20237:00 amRNSCapital Markets Day
13th Jan 20232:00 pmRNSDirector/PDMR Shareholding
10th Jan 202310:30 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 20224:00 pmRNSDirector/PDMR Shareholding
13th Dec 20226:25 pmRNSDirector/PDMR Shareholding
6th Dec 20224:15 pmRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Results
25th Oct 20227:00 amRNSTrading Update
28th Sep 20226:15 pmRNSResult of AGM
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
12th Jul 20227:00 amRNSQuarterly Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.